Year |
Citation |
Score |
2009 |
Keravala A, Lee S, Thyagarajan B, Olivares EC, Gabrovsky VE, Woodard LE, Calos MP. Mutational derivatives of PhiC31 integrase with increased efficiency and specificity Molecular Therapy. 17: 112-120. PMID 19002165 DOI: 10.1038/Mt.2008.241 |
0.781 |
|
2006 |
Chalberg TW, Portlock JL, Olivares EC, Thyagarajan B, Kirby PJ, Hillman RT, Hoelters J, Calos MP. Integration specificity of phage phiC31 integrase in the human genome. Journal of Molecular Biology. 357: 28-48. PMID 16414067 DOI: 10.1016/J.Jmb.2005.11.098 |
0.778 |
|
2006 |
Bertoni C, Jarrahian S, Wheeler TM, Li Y, Olivares EC, Calos MP, Rando TA. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. Proceedings of the National Academy of Sciences of the United States of America. 103: 419-24. PMID 16387861 DOI: 10.1073/Pnas.0504505102 |
0.7 |
|
2006 |
Keravala A, Lee S, Olivares EC, Thyagarajan B, Farruggio A, Gabrovsky VE, Calos MP. 525. Mutants of phiC31 Integrase with Increased Efficiency and Specificity Molecular Therapy. 13: S201-S202. DOI: 10.1016/J.Ymthe.2006.08.596 |
0.817 |
|
2006 |
Bertoni C, Jarrahian S, Wheeler TM, Li Y, Olivares EC, Calos MP, Rando TA. 34. Phi C31 Integrase System Enhances Dystrophin Gene Expression in Skeletal Muscle of Mouse Models for Duchenne Muscular Dystrophy Molecular Therapy. 13: S14-S15. DOI: 10.1016/J.Ymthe.2006.08.047 |
0.594 |
|
2005 |
Held PK, Olivares EC, Aguilar CP, Finegold M, Calos MP, Grompe M. In Vivo Correction of Murine Hereditary Tyrosinemia Type I by ϕC31 Integrase-Mediated Gene Delivery. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 399-408. PMID 28192681 DOI: 10.1016/j.ymthe.2004.11.001 |
0.745 |
|
2005 |
Held PK, Olivares EC, Aguilar CP, Finegold M, Calos MP, Grompe M. In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 399-408. PMID 15727936 DOI: 10.1016/J.Ymthe.2004.11.001 |
0.765 |
|
2005 |
Bertoni C, Jarrahian S, Wheeler TM, Li Y, Olivares EC, Calos MP, Rando TA. 265. Enhanced Plasmid-Mediated Dystrophin Expression in the mdx Mouse Model for Duchenne Muscular Dystrophy by a PhiC31 Integrase Plasmid System Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.268 |
0.619 |
|
2005 |
Portlock JL, Chalberg TW, Olivares EC, Thyagarajan B, Kirby PJ, Calos MP. 194. Characteristics of Site-Specific Integration as Mediated by PhiC31 Integrase in the Human Genome Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.197 |
0.766 |
|
2004 |
Quenneville SP, Chapdelaine P, Rousseau J, Beaulieu J, Caron NJ, Skuk D, Mills P, Olivares EC, Calos MP, Tremblay JP. Nucleofection of muscle-derived stem cells and myoblasts with φC31 integrase: Stable expression of a full-length-dystrophin fusion gene by human myoblasts Molecular Therapy. 10: 679-687. PMID 15451452 DOI: 10.1016/J.Ymthe.2004.05.034 |
0.742 |
|
2004 |
Chalberg TW, Ginsburg DS, Kirby PJ, Olivares EC, Portlock JL, Thyagarajan B, Calos MP. 814. Integration Sites Used by the PhiC31 Site-Specific Integrase in the Human Genome Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.712 |
0.728 |
|
2004 |
Wheeler TM, Jarrahian S, Bertoni C, Olivares EC, Doyle T, Contag CH, Calos MP, Rando TA. 810. Site-Specific Integration Enhances Expression of DNA Introduced into Skeletal Muscle Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.708 |
0.794 |
|
2004 |
Quenneville SP, Chapdelaine P, Rousseau J, Caron NJ, Skuk D, Olivares EC, Calos MP, Tremblay JP. 152. Nucleofection and phage phiC31 integrase mediate stable introduction of a dystrophin fusion gene into muscle derived stem cell and human myoblasts Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.075 |
0.733 |
|
2003 |
Olivares EC, Calos MP. Phage φC31 integrase-mediated site-specific integration for gene therapy Gene Therapy and Regulation. 2: 103-120. DOI: 10.1163/156855803322664600 |
0.825 |
|
2002 |
Olivares EC, Hollis RP, Chalberg TW, Meuse L, Kay MA, Calos MP. Site-specific genomic integration produces therapeutic factor IX levels in mice Nature Biotechnology. 20: 1124-1128. PMID 12379870 DOI: 10.1038/Nbt753 |
0.846 |
|
2001 |
Olivares EC, Hollis RP, Calos MP. Phage R4 integrase mediates site-specific integration in human cells. Gene. 278: 167-76. PMID 11707334 DOI: 10.1016/S0378-1119(01)00711-9 |
0.742 |
|
2001 |
Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP. Site-specific genomic integration in mammalian cells mediated by phage φC31 integrase Molecular and Cellular Biology. 21: 3926-3934. PMID 11359900 DOI: 10.1128/Mcb.21.12.3926-3934.2001 |
0.842 |
|
2000 |
Groth AC, Olivares EC, Thyagarajan B, Calos MP. A phage integrase directs efficient site-specific integration in human cells Proceedings of the National Academy of Sciences of the United States of America. 97: 5995-6000. PMID 10801973 DOI: 10.1073/Pnas.090527097 |
0.834 |
|
Show low-probability matches. |